Conspicuous sales rise for Celebrex

Pfizer's Celebrex gained a majority of sales for new-generation painkillers last year amid growing safety concerns over popular Gevorin and other acetaminophen drugs, according to Ubist market data.

Last year, sales of Celebrex topped 37.4 billion sales, showing more than 90 billion in each quarter’s sales.

SK Chemicals’ Joins came as second with 28 billion won, followed by Janssen’s Ultr...